Press release content from Business Wire. The AP news staff was not involved in its creation. Affinivax Appoints Stuart Chaffee, PhD, as Chief Business Officer April 20, 2021 GMT Affinivax Chief Business Officer Stuart Chaffee PhD (Photo: Business Wire) CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 20, 2021-- Affinivax, Inc. (“Affinivax”), a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS™ (Multiple Antigen Presenting System) platform, today announced that Stuart Chaffee, PhD, has joined the company as Chief Business Officer. Dr. C...